Bicycle Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update May 7, 2020
Bicycle Therapeutics Announces First Patient Dosed in Phase I Dose Escalation of BT5528 in Combination with Nivolumab May 5, 2020
Bicycle Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Corporate Updates March 10, 2020
Bicycle Therapeutics Announces Exclusive Strategic Collaboration with Genentech to Develop and Commercialize Bicycle®-based Immuno-oncology Therapies February 25, 2020
